- Home
- EXLS vs TECH Comparison
EXLS vs TECH Comparison
Compare EXLS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- TECH
- Stock Information
- Founded
- EXLS 1999
- TECH 1976
- Country
- EXLS United States
- TECH United States
- Employees
- EXLS N/A
- TECH N/A
- Industry
- EXLS Business Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXLS Consumer Discretionary
- TECH Health Care
- Exchange
- EXLS Nasdaq
- TECH Nasdaq
- Market Cap
- EXLS 7.0B
- TECH 7.9B
- IPO Year
- EXLS 2006
- TECH 1989
- Fundamental
- Price
- EXLS $46.86
- TECH $51.61
- Analyst Decision
- EXLS Strong Buy
- TECH Buy
- Analyst Count
- EXLS 8
- TECH 10
- Target Price
- EXLS $49.00
- TECH $73.44
- AVG Volume (30 Days)
- EXLS 1.6M
- TECH 2.3M
- Earning Date
- EXLS 04-29-2025
- TECH 05-07-2025
- Dividend Yield
- EXLS N/A
- TECH 0.62%
- EPS Growth
- EXLS 21.21
- TECH N/A
- EPS
- EXLS 1.32
- TECH 0.83
- Revenue
- EXLS $1,902,884,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- EXLS $13.96
- TECH $8.19
- Revenue Next Year
- EXLS $11.46
- TECH $8.61
- P/E Ratio
- EXLS $35.48
- TECH $62.17
- Revenue Growth
- EXLS 14.18
- TECH 4.72
- 52 Week Low
- EXLS $28.59
- TECH $46.44
- 52 Week High
- EXLS $52.43
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- EXLS 55.05
- TECH 49.54
- Support Level
- EXLS $45.04
- TECH $46.77
- Resistance Level
- EXLS $47.07
- TECH $54.40
- Average True Range (ATR)
- EXLS 1.55
- TECH 2.03
- MACD
- EXLS 0.18
- TECH 0.70
- Stochastic Oscillator
- EXLS 62.16
- TECH 63.43
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.